GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Tisato, Veronica ^a   Secchiero, Paola ^a   Rimondi, Erika ^b   Gianesini, Sergio ^a   Menegatti, Erica ^a   Casciano, Fabio ^a   Zamboni, Paolo ^a   Zauli, Giorgio ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; OSTEOPROTEGERIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN; TNFRSF11B PROTEIN, HUMAN;

ABLATION THERAPY; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC DISEASE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; SAPHENOUS VEIN; VEIN DISEASE; AGED; APOPTOSIS; CELL MEMBRANE; CELL MOTION; COHORT ANALYSIS; DOPPLER FLOWMETRY; DRUG EFFECT; GENE EXPRESSION REGULATION; HEMODYNAMICS; METABOLISM; MIDDLE AGED; TIME; VASCULAR DISEASE;

AGED; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMODYNAMICS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OSTEOPROTEGERIN; RECOMBINANT PROTEINS; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; ULTRASONOGRAPHY, DOPPLER; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES;

EID: 84890093066     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/561689     Document Type: Article

References (38)

1. Chiu J. J., Chien S., Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiological Reviews 2011 91 1 327 387 2-s2.0-78751652828 10.1152/physrev.00047.2009
2. Li Y. S., Haga J. H., Chien S., Molecular basis of the effects of shear stress on vascular endothelial cells. Journal of Biomechanics 2005 38 10 1949 1971 2-s2.0-23444452042 10.1016/j.jbiomech.2004.09.030 (Pubitemid 41111740)
3. Chiu J. J., Usami S., Chien S., Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis. Annals of Medicine 2009 41 1 19 28 2-s2.0-60549108384 10.1080/07853890802186921
4. Raffetto J. D., Dermal pathology, cellular biology, and inflammation in chronic venous disease. Thrombosis Research 2009 123 supplement 4 S66 S71 2-s2.0-62249119165 10.1016/S0049-3848(09)70147-1
5. Reček C., Conception of the venous hemodynamics in the lower extremity. Angiology 2006 57 5 556 563 2-s2.0-33750029602 10.1177/ 0003319706293117 (Pubitemid 44566366)
6. Zamboni P., Franceschi C., Principles of Venous Hemodynamics 2009 Hauppauge, NY, USA Nova Science Publishers
7. Lang I., Pabst M. A., Hiden U., Blaschitz A., Dohr G., Hahn T., Desoye G., Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. European Journal of Cell Biology 2003 82 4 163 173 2-s2.0-0038069208 10.1078/0171-9335-00306 (Pubitemid 36546617)
8. Eriksson E. E., Karlof E., Landmark K., Rotzius P., Hedin U., Xie X., Powerful inflammatory properties of large vein endothelium in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 4 723 728 2-s2.0-16244396470 10.1161/01.ATV.0000157578.51417.6f (Pubitemid 40463860)
9. Tisato V., Zauli G., Voltan R., Gianesini S., di Iasio M. G., Volpi I., Fiorentini G., Zamboni P., Secchiero P., Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. PLoS ONE 2012 7 6 e39543 10.1371/journal.pone.0039543
10. Tisato V., Zamboni P., Menegatti E., Gianesini S., Volpi I., Zauli G., Secchiero P., Endothelial PDGF-BB produced ex vivo correlates with relevant hemodynamic parameters in patients affected by chronic venous disease. Cytokine 2013 63 2 92 96 10.1016/j.cyto.2013.04.018
11. Secchiero P., Corallini F., Beltrami A. P., Ceconi C., Bonasia V., di Chiara A., Ferrari R., Zauli G., An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis 2010 210 1 274 277 2-s2.0-77952427166 10.1016/j.atherosclerosis.2009.11.005
12. Zauli G., Melloni E., Capitani S., Secchiero P., Role of full-length osteoprotegerin in tumor cell biology. Cellular and Molecular Life Sciences 2009 66 5 841 851 2-s2.0-63049093672 10.1007/s00018-008-8536-x
13. Secchiero P., Zauli G., Tumor necrosis factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Current Opinion in Hematology 2008 15 1 42 48 2-s2.0-36549083012 10.1097/MOH.0b013e3282f15fa6 (Pubitemid 350191027)
14. Secchiero P., Gonelli A., Celeghini C., Mirandola P., Guidotti L., Visani G., Capitani S., Zauli G., Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Blood 2001 98 7 2220 2228 2-s2.0-0035496908 10.1182/blood.V98.7.2220
15. Zauli G., Corallini F., Bossi F., Fischetti F., Durigutto P., Celeghini C., Tedesco F., Secchiero P., Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 2007 110 2 536 543 2-s2.0-34547129112 10.1182/blood-2007-01-068395 (Pubitemid 47105391)
16. Wong V. W., Crawford J. D., Vasculogenic cytokines in wound healing. BioMed Research International 2013 2013 11 190486 10.1155/2013/190486
17. Grochot-Przeczek A., Dulak J., Jozkowicz A., Therapeutic angiogenesis for revascularization in peripheral artery disease. Gene 2013 525 2 220 228 10.1016/j.gene.2013.03.097
18. + hemangiocytes. Nature Medicine 2006 12 5 557 567 10.1038/nm1400
19. Grote K., Schuett H., Salguero G., Grothusen C., Jagielska J., Drexler H., Mühlradt P. F., Schieffer B., Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration. Blood 2010 115 12 2543 2552 2-s2.0-77950554962 10.1182/blood-2009-05-224402
20. Re M. C., Zauli G., Gibellini D., Furlini G., Ramazzotti E., Monari P., Ranieri S., Capitani S., La Placa M., Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 1993 7 8 1049 1055 2-s2.0-0027201115 (Pubitemid 23246447)
21. Zauli G., La Placa M., Vignoli M., Re M. C., Gibellini D., Furlini G., Milani D., Marchisio M., Mazzoni M., Capitani S., An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995 10 3 306 316 2-s2.0-0028843803
22. Vitale M., Zamai L., Falcieri E., Zauli G., Gobbi P., Santi S., Cinti C., Weber G., IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells. Cytometry B 1997 30 1 61 66 10.1002/(SICI)1097- 0320(19970215)30:1<61::AID-CYTO9>3.0.CO;2-I
23. Secchiero P., Melloni E., di Iasio M. G., Tiribelli M., Rimondi E., Corallini F., Gattei V., Zauli G., Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. Blood 2009 113 18 4300 4308 2-s2.0-66149108372 10.1182/blood-2008-11-187708
24. Zauli G., Bassini A., Vitale M., Gibellini D., Celeghini C., Caramelli E., Pierpaoli S., Guidotti L., Capitani S., Thrombopoietin enhances the α (IIb) β 3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. Blood 1997 89 3 883 895 2-s2.0-0030952228 (Pubitemid 27121281)
25. Bussolino F., Ziche M., Wang J. M., Alessi D., Morbidelli L., Cremona O., Bosia A., Marchisio P. C., Mantovani A., In vitro and in vivo activation of endothelial cells by colony-stimulating factors. Journal of Clinical Investigation 1991 87 3 986 995 2-s2.0-0025829752
26. Ebner K., Bandion A., Binder B. R., de Martin R., Schmid J. A., GMCSF activates NF- B via direct interaction of the GMCSF receptor with I B kinase β Blood 2003 102 1 192 199 2-s2.0-0038644520 10.1182/blood-2002-12-3753 (Pubitemid 36759654)
27. Wakefield T. W., Strieter R. M., Prince M. R., Downing L. J., Greenfield L. J., Pathogenesis of venous thrombosis: a new insight. Cardiovascular Surgery 1997 5 1 6 15 2-s2.0-0030977998 10.1016/S0967-2109(96)00083-X (Pubitemid 27219718)
28. Eberhardt R. T., Raffetto J. D., Chronic venous insufficiency. Circulation 2005 111 18 2398 2409 2-s2.0-18444412628 10.1161/01.CIR.0000164199. 72440.08 (Pubitemid 40647076)
29. Müller A. M., Hermanns M. I., Cronen C., Kirkpatrick C. J., Comparative study of adhesion molecule expression in cultured human macro- and microvascular endothelial cells. Experimental and Molecular Pathology 2002 73 3 171 180 2-s2.0-0036987908 10.1006/exmp.2002.2446 (Pubitemid 38367364)
30. Lang I., Hoffmann C., Olip H., Pabst M. A., Hahn T., Dohr G., Desoye G., Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Proliferation 2001 34 3 143 155 10.1046/j.1365-2184.2001.00205.x (Pubitemid 32523216)
31. Eriksson E. E., Karlof E., Landmark K., Rotzius P., Hedin U., Xie X., Powerful inflammatory properties of large vein endothelium in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 4 723 728 2-s2.0-16244396470 10.1161/01.ATV.0000157578.51417.6f (Pubitemid 40463860)
32. Lawson C., Wolf S., ICAM-1 signaling in endothelial cells. Pharmacological Reports 2009 61 1 22 32 2-s2.0-66949136652
33. Alcaide P., Maganto-Garcia E., Newton G., Travers R., Croce K. J., Bu D. X., Luscinskas F. W., Lichtman A. H., Difference in Th1 and Th17 lymphocyte adhesion to endothelium. Journal of Immunology 2012 188 3 1421 1430 2-s2.0-84856560521 10.4049/jimmunol.1101647
34. Montagnana M., Lippi G., Danese E., Guidi G. C., The role of osteoprotegerin in cardiovascular disease. Annals of Medicine 2013 45 3 254 264 10.3109/07853890.2012.727019
35. Kosaki K., Ando J., Korenaga R., Kurokawa T., Kamiya A., Fluid shear stress increases the production of granulocyte-macrophage colony-stimulating factor by endothelial cells via mRNA stabilization. Circulation Research 1998 82 7 794 802 2-s2.0-0032550288 (Pubitemid 28185847)
36. Krubasik D., Eisenach P. A., Kunz-Schughart L. A., Murphy G., English W. R., Granulocyte-macrophage colony stimulating factor induces endothelial capillary formation through induction of membrane-type 1 matrix metalloproteinase expression in vitro. International Journal of Cancer 2008 122 6 1261 1272 2-s2.0-39649103854 10.1002/ijc.23234 (Pubitemid 351287225)
37. Horneber M., Milazzo S., Liu J. P., Marcel Z., Birkmann J., Colony-stimulating factors for the prevention of chemotherapy induced febrile neutropenia in breast cancer patients. Cochrane Database of Systematic Reviews 2009 3 2-s2.0-70049089289 10.1002/14651858.CD007913 CD007913
38. Bo L., Wang F., Zhu J., Li J., Deng X., Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Critical Care 2011 15 1, article R58 2-s2.0-79751531129 10.1186/cc10031